Zhejiang Wanma Pharmaceutical

Zhejiang Wanma Pharmaceutical Co., Ltd. is a China-based pharmaceutical company and a core subsidiary of the Zhejiang Wanma Group. Established in 1994, the company focuses on the development, manufacturing, and commercialization of chemical drug preparations and active pharmaceutical ingredients (APIs). Its extensive product portfolio is centered on cardiovascular health, anti-infectives, and gastrointestinal treatments, featuring well-known generic medications such as amlodipine and azithromycin. The company maintains modern, GMP-compliant production facilities in the Deqing Economic Development Zone. Zhejiang Wanma Pharmaceutical is recognized as a high-tech enterprise in Zhejiang Province, contributing significantly to the regional healthcare industry through its integrated R&D and manufacturing capabilities.